Presentation Information
[PE5-3]Integrated germline and somatic cancer testing provide opportunity to identify cancer risk and resolve variant origins
○Reiko Nishiguchi1, Kingshuk Das2, Amber Carter2, Brandie Heald2, Scott Michalski2, Sarah Nielsen2, Nhu Ngo2, Sara Elrefai3, Kelly Warsinske3, Stacy Lenarcic3, Heather Hampel4, Robert Nussbaum2, Edward Esplin2 (1.Department of Global Medical Affairs, Invitae Japan, Tokyo, Japan, 2.Invitae Inc., San Francisco, USA, 3.Atrium Health, Charlotte, USA, 4.The Ohio State University Medical Center, Columbus, USA)